Melanoma other diagnostic studies: Difference between revisions

	Melanoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Melanoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Melanoma other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Melanoma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Melanoma other diagnostic studies
CDC on Melanoma other diagnostic studies
Melanoma other diagnostic studies in the news
Blogs on Melanoma other diagnostic studies
Directions to Hospitals Treating Melanoma
Risk calculators and risk factors for Melanoma other diagnostic studies

Revision as of 21:03, 24 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 4: / Line 4: @@
 ==Overview==
-==Future techniques==
-<p>In addition to identifying high-risk patients, researchers also want to identify high-risk lesions within a given patient.  Many new technologies, such as [[optical coherence tomography]] (OCT), are being developed to accomplish this.  OCT allows pathologists to view 3-D reconstructions of the skin and offers more resolution than past techniques could provide.  In vivo [[confocal microscopy]] and fluorescently tagged [[antibodies]] are also proving to be valuable diagnostic tools.
 ==References==